© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
HIV
Health Plan Leaders Can Step Up, Lead on PrEP Services
August 02, 2021
Amida Care’s Doug Wirth says they should work with state-level officials to make sure services are covered after Biden administration’s guidance that coverage is mandatory.
Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment
August 01, 2021
The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.
Biden Budget Proposes Increased Funding for Ending HIV, But Not for Hepatitis Programs
June 05, 2021
Biden is proposing a $46 million increase to the Ryan White HIV/AIDS Programs and $20 million for HUD’s Housing Opportunities for Persons with AIDS program. However, no increases were planned for hepatitis programs.
AIDS Group Says ACA Plan Copay Accumulators are More Common Than Not
May 10, 2021
Copay accumulators are a common feature in health insurance plans sold on the ACA exchanges, according to a recent report from an AIDS advocacy group that wants the Biden administration to reverse a decision made by the Trump administration that allowed continued use of accumulators.
Are People Living With HIV More Vulnerable to COVID-19?
May 03, 2021
The jury is still out, but the evidence is accumulating that people with HIV with comorbidities such as diabetes may be at greater risk for hospitalization from COVID-19.
Access to Virtual HIV Prevention, HIV care and Gender Affirming Care in Rural Areas Expands
May 02, 2021
Improvements in prevention toward HIV is starting in Texas through Texas Health Action. The health organization is creating a virtual HIV prevention service available toward HIV care and gender affirming care in rural areas.
HIV As a Chronic Disease: Study Shows Link Between Neurocognitive Impairment, Quality of Life
April 06, 2021
Findings add to the understanding of the challenges that people living with HIV face now that it is a more manageable, long-term condition.
Commonly Prescribed Diabetes Drug May Be Useful in Fight Against HIV
April 01, 2021
If replicated in future studies, the findings have important implications for the millions of people living with HIV, many of which display signs of residual viral replication despite treatment.
HIV Med Market To Reach $28B in 2029
March 08, 2021
Market research firm sees growth in sales for injectable therapies developed with an eye toward improving adherence. Sales in pre-exposure prophylaxis are also projected to increase.
Jury Still Out on Whether Telehealth Is a Plus or Minus for HIV Amid the COVID-19 Pandemic
March 08, 2021
The rapid implementation of telehealth viewed favorably by providers involved in HIV care yet there are conflicting results on how well it facilitates patient retention.